Abstract:Background: Omalizumab (XOLAIR®)-assisted multi-food oral immunotherapy (mOIT) has been shown to safely, effectively, and rapidly desensitize patients with multiple food allergies. In our clinical trial (NCT02626611) on omalizumab-assisted mOIT, different desensitization outcomes (success or failure of desensitization) were observed following a period of either continued or discontinued mOIT. However, the association between the immunological changes induced by omalizumab-assisted mOIT and desensitization outcomes has not yet been fully elucidated. In this study, due to the key roles of regulatory T (Treg) cells and the type 2 helper T cell (Th2) pathway in immune tolerance to food allergens, we aimed to characterize their association with the desensitization outcomes of omalizumab-assisted mOIT. Methods: Mass cytometry and multiplex cytokine assays were performed on blood samples obtained from participants with allergies to peanut, cashew, or milk in our phase 2 clinical study (NCT02626611). Comprehensive statistical and bioinformatic analyses were conducted on high-dimensional cytometry-based single-cell data and high-throughput multiplex cytokine data. Results: Our results demonstrated that the frequency of HLA-DR+ Treg cells, and the production of Th2 cytokines (IL-4, IL-5, IL-13, and IL-9) as well as the immunoregulatory cytokine IL-10 by peripheral blood mononuclear cells (PBMCs) was significantly increased in cultures with allergen compared to cultures with media alone at baseline (Week 0). We also observed increased frequency of allergen responsive HLA-DR+ Treg cells and enhanced production of IL-10 by PBMCs in participants who achieved successful desensitization compared to those with failure of desensitization. However, the production of Th2 cytokines by PBMCs did not show significant differences between participants with different desensitization outcomes (success vs. failure of desensitization), despite omalizumab-assisted mOIT inducing a significant reduction in the production of Th2 cytokines. Conclusions: We demonstrated that the frequency of HLA-DR+ Treg cells and IL-10 cytokine production by PBMCs are associated with desensitization outcomes of omalizumab-assisted mOIT. These findings suggest potential immunological parameters that could be targeted to enhance desensitization success rates.

A positive feedback loop reinforces the allergic immune response in human peanut allergy

Joint transcriptomic and cytometric study of peanut allergic children reveals molecular and cellular cross-talk in reaction thresholds

Fructo-Oligosaccharides Modify Human DC Maturation and Peanut-Induced Autologous T-Cell Response of Allergic Patients In Vitro

Airway exposure initiates peanut allergy by involving the IL-1 pathway and T follicular helper cells in mice

Group 2 Innate Lymphoid Cells Promote Development of T Follicular Helper Cells and Initiate Allergic Sensitization to Peanuts

Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells

Dendritic cells in food allergy, treatment, and tolerance

Traffic of eosinophil-lineage committed progenitors to the lung tissue of sensitised mice following allergen challenge

Role of dendritic cells in peanut allergy

CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy

The potential of orally exposed risk factors and constituents aggravating food allergy: Possible mechanism and target cells

Transcriptomic changes associated with oral immunotherapy for food allergy

A therapeutic strategy to target distinct sources of IgE and durably reverse allergy

Different airborne particulates trigger distinct immune pathways leading to peanut allergy in a mouse model

Altered natural killer cell responses linked to allergen sensitization in patients with atopic dermatitis

Effects of Allergen Immunotherapy on Follicular Regulatory T Cells

Regulating Bcl2L12 Expression in Mast Cells Inhibits Food Allergy

HLA-DR+ regulatory T cells and IL-10 are associated with success or failure of desensitization outcomes

Allergen-specific IgA and IgG antibodies as inhibitors of mast cell function in food allergy

Protection Against the Allergic Airway Inflammation Depends on the Modulation of Spleen Dendritic Cell Function and Induction of Regulatory T Cells in Mice

The Bile Acid-Activated Retinoic Acid Response in Dendritic Cells is Involved in Food Allergen Sensitization.